Family Medicine Doctors in Washington Twp, MI Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Dr. Janis Elizabeth Romanik, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 12150 30 Mile Rd, Suite 201, Washington Twp, MI 48095 Phone: 586-336-2380 Fax: 586-336-2381 |
Jill Schmitt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 64321 Van Dyke Rd, Beaumont Clearwater Family Practice, Washington Twp, MI 48095 Phone: 586-281-6000 Fax: 586-281-6001 |
Dr. Renee Susko, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 64253 Van Dyke Rd, Washington Twp, MI 48095 Phone: 586-789-5992 |
News Archive
FRC opposes designating abortion as means of pregnancy-prevention
At a meeting today in the nation's capital of a federal advisory committee on the new health care law, Family Research Council (FRC) expressed its strong opposition to designating abortion as a means of pregnancy-prevention. The Institute of Medicine Committee on Preventive Services for Women is hearing comments about regulatory mandates for women's preventive services under Obamacare.
Scientific data confirms therapeutic potential of Anavex's S1R agonist against Parkinson's disease
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company developing novel drug candidates to treat Alzheimer's, other diseases of the central nervous system (CNS) and various types of cancer, today announced the findings of a research study published in the current issue of peer-reviewed scientific journal Brain.
Pfizer's Prevenar 13 granted European marketing authorization
The European Commission has granted Pfizer Inc. a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Invasive pneumococcal disease includes sepsis, meningitis, bacteremia, bacteremic pneumonia, and empyema.
Teva initiates enrollment in AZILECT Phase IV clinical study for PD-MCI
Teva Pharmaceutical Industries Ltd. announced today enrollment of the first patient in the MODERATO study - a Phase IV clinical study designed to evaluate the effect of AZILECT (rasagiline tablets) on cognitive function in adults with mild cognitive impairment (MCI) in Parkinson's disease (PD-MCI).
› Verified 1 days ago